1. Home
  2. ITCI vs CART Comparison

ITCI vs CART Comparison

Compare ITCI & CART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITCI
  • CART
  • Stock Information
  • Founded
  • ITCI 2002
  • CART 2012
  • Country
  • ITCI United States
  • CART United States
  • Employees
  • ITCI N/A
  • CART N/A
  • Industry
  • ITCI Biotechnology: Pharmaceutical Preparations
  • CART
  • Sector
  • ITCI Health Care
  • CART
  • Exchange
  • ITCI Nasdaq
  • CART Nasdaq
  • Market Cap
  • ITCI 8.0B
  • CART 11.5B
  • IPO Year
  • ITCI N/A
  • CART 2023
  • Fundamental
  • Price
  • ITCI $86.40
  • CART $44.60
  • Analyst Decision
  • ITCI Strong Buy
  • CART Buy
  • Analyst Count
  • ITCI 12
  • CART 24
  • Target Price
  • ITCI $97.00
  • CART $44.53
  • AVG Volume (30 Days)
  • ITCI 459.9K
  • CART 2.6M
  • Earning Date
  • ITCI 10-30-2024
  • CART 11-12-2024
  • Dividend Yield
  • ITCI N/A
  • CART N/A
  • EPS Growth
  • ITCI N/A
  • CART N/A
  • EPS
  • ITCI N/A
  • CART N/A
  • Revenue
  • ITCI $564,526,000.00
  • CART $3,210,000,000.00
  • Revenue This Year
  • ITCI $46.60
  • CART $13.05
  • Revenue Next Year
  • ITCI $37.06
  • CART $8.87
  • P/E Ratio
  • ITCI N/A
  • CART N/A
  • Revenue Growth
  • ITCI 54.31
  • CART 10.69
  • 52 Week Low
  • ITCI $46.10
  • CART $22.13
  • 52 Week High
  • ITCI $84.89
  • CART $45.20
  • Technical
  • Relative Strength Index (RSI)
  • ITCI 73.36
  • CART 65.06
  • Support Level
  • ITCI $75.57
  • CART $44.18
  • Resistance Level
  • ITCI $79.46
  • CART $45.20
  • Average True Range (ATR)
  • ITCI 2.42
  • CART 1.21
  • MACD
  • ITCI 0.60
  • CART -0.06
  • Stochastic Oscillator
  • ITCI 88.13
  • CART 78.42

About ITCI Intra-Cellular Therapies Inc.

Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.

About CART Maplebear Inc.

Maplebear (Instacart) operates a leading grocery delivery platform in the United States and Canada. The firm partners with various regional and national grocers, which offer their selection of food and other goods to customers through Instacart's ubiquitous platform. Once an item is ordered through Instacart's site, the item is picked and delivered to the customer's home by one of the platform's 600,000 shoppers, who are classified as independent contractors. Instacart earns fees based on average order value and leverages its platform's high usage to sell advertising, mainly to consumer-packaged goods companies. Instacart currently has nearly 8 million monthly active users (or orderers) on its platform.

Share on Social Networks: